Vicini S
FIDIA-Georgetown Institute for the Neurosciences, Washington, D.C. 20007.
Neuropsychopharmacology. 1991 Jan;4(1):9-15.
Gamma-Aminobutyric acidA (GABAA) receptors are heterooligomeric proteins with an apparent high degree of variability in the specific assembly of their component subunits. Although the precise nucleotide and deduced amino acid sequences of many of the various GABAA receptor subunits are known, the exact quaternary structures of the native receptors are unknown. Recombinant expression of receptors with different combinations of subunits produces a variety of structurally different receptors with varying Cl- channel function and sensitivities to modulation by drugs such as benzodiazepines. Differences in the regional distribution of GABAA receptor subtypes in brain, coupled with the observed differences in the relative affinities of various anxiolytic and hypnotic drugs among these receptor subtypes, suggests a new strategy for drug development that is the targeting of drugs to specific subpopulations of GABAA receptors. This is a review of the recent striking progress in understanding the heterogeneity of the GABAA receptors and its possible significance.
γ-氨基丁酸A(GABAA)受体是异源寡聚体蛋白,其组成亚基的特定组装具有明显的高度变异性。尽管许多不同的GABAA受体亚基的确切核苷酸和推导的氨基酸序列是已知的,但天然受体的确切四级结构尚不清楚。用不同亚基组合重组表达受体可产生多种结构不同的受体,它们具有不同的氯离子通道功能以及对诸如苯二氮䓬类药物调节的敏感性。脑内GABAA受体亚型区域分布的差异,再加上观察到的各种抗焦虑和催眠药物在这些受体亚型之间相对亲和力的差异,提示了一种新的药物开发策略,即针对特定GABAA受体亚群的药物靶向。本文综述了在理解GABAA受体异质性及其可能意义方面最近取得的显著进展。